Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4)

Rheumatoid arthritis (RA), osteoarthritis (OA), and gout are the most prevalent degenerative joint diseases (DJDs). The pathogenesis underlying joint disease in DJDs remains unclear. Considering the severe toxicities reported with anti-inflammatory and disease-modifying agents, there is a clear need...

Descripción completa

Detalles Bibliográficos
Autor principal: Qadri, Marwa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609794/
https://www.ncbi.nlm.nih.gov/pubmed/37895896
http://dx.doi.org/10.3390/ph16101425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609794/
https://www.ncbi.nlm.nih.gov/pubmed/37895896
http://dx.doi.org/10.3390/ph16101425

Ejemplares similares